1. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.
- Author
-
Sesso R, Eisenberg JM, Stabile C, Draibe S, Ajzen H, and Ramos O
- Subjects
- Adolescent, Adult, Brazil, Cost-Benefit Analysis, Humans, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Middle Aged, Survival Rate, Kidney Failure, Chronic economics, Kidney Transplantation economics, Peritoneal Dialysis, Continuous Ambulatory economics, Renal Dialysis economics
- Abstract
Cost-effectiveness analysis compared four treatments of end-stage renal disease in Brazil: continuous ambulatory peritoneal dialysis (CAPD), in-center hemodialysis (HD), cadaver donor transplantation (CD-Tx), and living related donor transplantation (LR-Tx). After 2 years, the costs per year of survival were CAPD, $12,134; HD, $10,065; CD-Tx, $6,978; and LR-Tx, $3,022. The HD cost was lower than CAPD partially because of the reuse of hemodialyzers in Brazil. Although less cost-effective, both dialysis treatments yielded more years of survival after 2 years. This analysis reveals a trade-off between cost per year of survival and years of survival.
- Published
- 1990
- Full Text
- View/download PDF